IGC Straddle Strategy
IGC (IGC Pharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on AMEX.
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
IGC (IGC Pharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $29.2M, a beta of 0.50 versus the broader market, a 52-week range of 0.24-0.5, average daily share volume of 1.1M, a public-listing history dating back to 2006, approximately 67 full-time employees. These structural characteristics shape how IGC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.50 indicates IGC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on IGC?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current IGC snapshot
As of May 15, 2026, spot at $0.29, ATM IV 27.10%, IV rank 2.03%, expected move 7.77%. The straddle on IGC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on IGC specifically: IGC IV at 27.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a IGC straddle, with a market-implied 1-standard-deviation move of approximately 7.77% (roughly $0.02 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IGC expiries trade a higher absolute premium for lower per-day decay. Position sizing on IGC should anchor to the underlying notional of $0.29 per share and to the trader's directional view on IGC stock.
IGC straddle setup
The IGC straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IGC near $0.29, the first option leg uses a $0.29 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IGC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IGC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.29 | N/A |
| Buy 1 | Put | $0.29 | N/A |
IGC straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
IGC straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on IGC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on IGC
Straddles on IGC are pure-volatility plays that profit from large moves in either direction; traders typically buy IGC straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
IGC thesis for this straddle
The market-implied 1-standard-deviation range for IGC extends from approximately $0.27 on the downside to $0.31 on the upside. A IGC long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current IGC IV rank near 2.03% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IGC at 27.10%. As a Healthcare name, IGC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IGC-specific events.
IGC straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IGC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IGC alongside the broader basket even when IGC-specific fundamentals are unchanged. Always rebuild the position from current IGC chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on IGC?
- A straddle on IGC is the straddle strategy applied to IGC (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With IGC stock trading near $0.29, the strikes shown on this page are snapped to the nearest listed IGC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IGC straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the IGC straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 27.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IGC straddle?
- The breakeven for the IGC straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IGC market-implied 1-standard-deviation expected move is approximately 7.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on IGC?
- Straddles on IGC are pure-volatility plays that profit from large moves in either direction; traders typically buy IGC straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current IGC implied volatility affect this straddle?
- IGC ATM IV is at 27.10% with IV rank near 2.03%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.